Comments: US HB4278 | 2021-2022 | 117th Congress

Bill Title: To direct the Comptroller General of the United States to conduct a study on how direct-to-consumer pharmaceutical advertising negatively impacts drug costs to consumers, and for other purposes.

Spectrum: Partisan Bill (Republican 2-0)

Status: (Introduced - Dead) 2021-07-01 - Referred to the Subcommittee on Health. [HB4278 Detail]

Text: Latest bill text (Introduced) [PDF]

PolitiCorps Conversations

Start PolitiCorps Debate
TitlePolitiCorpsAccessCommentsViewsLast Post
There are no visible public or private PolitiCorps discussions concerning the 2021 US Congress HB4278 at this time.

Social Comments on US HB4278

feedback